331920 Stock Chart & Stats
₩8600.00
-₩440.00(-4.87%)
―
--
Day’s Range― - ―
52-Week Range₩2,535.00 - ₩19,840.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)47.55K
Market Cap
₩96.16B
Enterprise Value₩95.15K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.17
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-535.05
Shares Outstanding11,181,555
10 Day Avg. Volume42,921
30 Day Avg. Volume47,546
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
331920 FAQ
What was Celemics, Inc.’s price range in the past 12 months?
Celemics, Inc. lowest stock price was ₩2535.00 and its highest was ₩19840.00 in the past 12 months.
What is Celemics, Inc.’s market cap?
Celemics, Inc.’s market cap is ₩96.16B.
When is Celemics, Inc.’s upcoming earnings report date?
Celemics, Inc.’s upcoming earnings report date is Nov 18, 2026 which is in 87 days.
How were Celemics, Inc.’s earnings last quarter?
Celemics, Inc. released its earnings results on Aug 14, 2026. The company reported -₩535.048 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Celemics, Inc. overvalued?
According to Wall Street analysts Celemics, Inc.’s price is currently Undervalued.
Does Celemics, Inc. pay dividends?
Celemics, Inc. does not currently pay dividends.
What is Celemics, Inc.’s EPS estimate?
Celemics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celemics, Inc. have?
Celemics, Inc. has 11,181,555 shares outstanding.
What happened to Celemics, Inc.’s price movement after its last earnings report?
Celemics, Inc. reported an EPS of -₩535.048 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.203%.
Which hedge fund is a major shareholder of Celemics, Inc.?
Currently, no hedge funds are holding shares in KR:331920
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genexine, Inc.
―
Aptabio Therapeutics, Inc.
―
ViGenCell, Inc.
―
TiumBio Co., Ltd.
―
VUNO Inc.
―